The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy

Chimeric antigen receptor T (CAR-T) cells are a treatment option for patients with relapse/refractory (R/R) non-Hodgkin lymphoma (NHL), acute lymphoid leukemia and multiple myeloma. To date, diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and chronic lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagna, Luca, Bono, Roberto, Tringali, Stefania, Sapienza, Giuseppe, Santoro, Alessandra, Indovina, Alessandro, Tarantino, Vittoria, Di Noto, Laura, Maggio, Aurelio, Patti, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763323/
https://www.ncbi.nlm.nih.gov/pubmed/36561713
http://dx.doi.org/10.3389/fmed.2022.1072192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763323/
https://www.ncbi.nlm.nih.gov/pubmed/36561713
http://dx.doi.org/10.3389/fmed.2022.1072192

Ejemplares similares